Literature DB >> 3068804

Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature.

D M van der Heijde1, P L van Riel, M H van Rijswijk, L B van de Putte.   

Abstract

The literature on prognostic features on the final outcome in RA is reviewed. It is generally agreed that female sex and a positive RF are variables indicating a poor prognosis. Longstanding increased ESR and CRP values, decreased Hb, or the appearance of subcutaneous nodules are indicators of a less favorable clinical course. No conclusions can be drawn regarding other factors due to the incomplete and heterogeneous study designs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3068804     DOI: 10.1016/0049-0172(88)90013-3

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  27 in total

1.  Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study.

Authors:  A Stockman; B D Tait; R Wolfe; C A Brand; M J Rowley; M D Varney; R Buchbinder; K D Muirden
Journal:  Rheumatol Int       Date:  2005-09-07       Impact factor: 2.631

2.  Predictors of functional status in patients with early rheumatoid arthritis.

Authors:  L M Jansen; D van Schaardenburg; I E van Der Horst-Bruinsma; P D Bezemer; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 3.  Prognostic factors of severe rheumatoid arthritis.

Authors:  R Westhovens
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 4.  Inflammation and rheumatoid arthritis.

Authors:  Amit Kumar Shrivastava; Aparna Pandey
Journal:  J Physiol Biochem       Date:  2012-10-31       Impact factor: 4.158

5.  Characteristics of rheumatoid arthritis in Algeria: a multicenter study.

Authors:  Samy Slimani; Abdelmalek Abbas; Amina Ben Ammar; Djemaa Kebaili; El Hadi Ali; Fadia Rahal; Mohamed Choukri Khamari; Ayada Baltache; Imene Khider; Riad Chiheub; Khireddine Khelif; Sabrina Akbi; Salima Rahmani; Chafia Dahou-Makhloufi; Nadjia Brahimi-Mazouni; Sabira Abtroun-Benmadi; Aicha Ladjouze-Rezig
Journal:  Rheumatol Int       Date:  2014-03-15       Impact factor: 2.631

6.  Cigarette smoking and rheumatoid arthritis severity.

Authors:  K G Saag; J R Cerhan; S Kolluri; K Ohashi; G W Hunninghake; D A Schwartz
Journal:  Ann Rheum Dis       Date:  1997-08       Impact factor: 19.103

7.  Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis.

Authors:  F Eggelmeijer; H G Otten; H H de Rooy; M R Daha; F C Breedveld
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

8.  Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?

Authors:  H A Capell; D R Porter; R Madhok; J A Hunter
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

9.  A T cell receptor beta chain variable region polymorphism associated with radiographic progression in rheumatoid arthritis.

Authors:  N de Vries; C F Prinsen; E B Mensink; P L van Riel; M A van't Hof; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

10.  Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis.

Authors:  Yoo Seob Shin; Jeong Hee Choi; Dong Ho Nahm; Hae Sim Park; Jae Hyun Cho; Chang Hee Suh
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.